Queensland Government Rejects National Expert Advice on Puberty Blocker Policy
By Chloe · Published 18 Nov 2026 · Updated 18 Nov 2026
Brisbane, QLD · Queensland News
Safety note: Admin approval is an initial review, not a guarantee that every detail is correct. Check important or urgent claims with official sources and report anything inaccurate or unsafe.
Source and credit: Contributor's own report
Queensland Government Rejects National Expert Advice on Puberty Blocker Policy - Brisbane, QLD
Smart summary
Queensland's government has rejected calls to reconsider restrictions on puberty-suppressing medication for young transgender people, following new interim advice from Australia's national health research body.
The Queensland Government has rejected calls to reconsider its restrictions on puberty-suppressing medication for young transgender and gender-diverse people, following new interim medical advice released by Australia's National Health and Medical Research Council (NHMRC).
The issue became a major topic of discussion on 18 November 2026 after parents and advocacy organisations called on the state government to review its existing policy. The national health advisory body's recommendations have reopened debate about how young people should access specialist healthcare across Australia.
The NHMRC recently released interim advice following a review of available medical evidence. Its recommendations state that puberty-suppressing medication can be considered for certain young people under 18 following an individual clinical assessment and shared decision-making involving the young person, their parents or carers and treating clinicians.
The advisory body made a conditional recommendation rather than suggesting that the medication should automatically be prescribed to every patient. It emphasised that treatment decisions must consider individual circumstances, potential benefits, possible risks and the available medical evidence.
However, Queensland Health Minister Tim Nicholls said the state government's position would remain unchanged. Queensland previously introduced restrictions on new prescriptions of puberty blockers for young people with gender dysphoria in the public healthcare system. The government has indicated that these restrictions will continue until at least 2031.
The Queensland Government said its position was based on an earlier independent review examining the available evidence surrounding puberty blockers and hormone treatments. The state has maintained that the health, safety and wellbeing of young Queenslanders remain its priority.
The national recommendations have also attracted attention from parents who believe that the existing restrictions should be reconsidered. Some families have expressed concerns about accessing appropriate specialist services and the impact that delays in healthcare decisions can have on young people.
The debate has highlighted differences between national medical advice and state-level healthcare policies. Although the NHMRC provides guidance based on its review of scientific evidence, its interim recommendations are not legally binding on individual state governments.
This means Queensland can continue implementing its existing restrictions even when national health experts recommend that the treatment remain a clinical option in certain circumstances.
The federal government has encouraged states and territories to carefully consider the NHMRC's advice. However, decisions about the delivery of public healthcare services remain the responsibility of individual jurisdictions.
The Northern Territory has also maintained restrictions on the treatment, demonstrating that the issue extends beyond Queensland.
The NHMRC is expected to continue developing comprehensive national clinical guidelines for the care of transgender and gender-diverse people under 18. These guidelines are scheduled for release in 2028 and are intended to provide a more consistent framework for healthcare professionals across Australia.
For now, Queensland's existing policy remains in place, and no immediate change to public healthcare access has been announced.
The discussion is expected to continue as medical organisations, families, policymakers and advocacy groups examine the evidence and consider how healthcare decisions should be made in the future.
HealthcareQueenslandGovernmentNationalYoung
The Queensland Government has rejected calls to reconsider its restrictions on puberty-suppressing medication for young transgender and gender-diverse people, following new interim medical advice released by Australia's National Health and Medical Research Council (NHMRC).
The issue became a major topic of discussion on 18 November 2026 after parents and advocacy organisations called on the state government to review its existing policy. The national health advisory body's recommendations have reopened debate about how young people should access specialist healthcare across Australia.
The NHMRC recently released interim advice following a review of available medical evidence. Its recommendations state that puberty-suppressing medication can be considered for certain young people under 18 following an individual clinical assessment and shared decision-making involving the young person, their parents or carers and treating clinicians.
The advisory body made a conditional recommendation rather than suggesting that the medication should automatically be prescribed to every patient. It emphasised that treatment decisions must consider individual circumstances, potential benefits, possible risks and the available medical evidence.
However, Queensland Health Minister Tim Nicholls said the state government's position would remain unchanged. Queensland previously introduced restrictions on new prescriptions of puberty blockers for young people with gender dysphoria in the public healthcare system. The government has indicated that these restrictions will continue until at least 2031.
The Queensland Government said its position was based on an earlier independent review examining the available evidence surrounding puberty blockers and hormone treatments. The state has maintained that the health, safety and wellbeing of young Queenslanders remain its priority.
The national recommendations have also attracted attention from parents who believe that the existing restrictions should be reconsidered. Some families have expressed concerns about accessing appropriate specialist services and the impact that delays in healthcare decisions can have on young people.
The debate has highlighted differences between national medical advice and state-level healthcare policies. Although the NHMRC provides guidance based on its review of scientific evidence, its interim recommendations are not legally binding on individual state governments.
This means Queensland can continue implementing its existing restrictions even when national health experts recommend that the treatment remain a clinical option in certain circumstances.
The federal government has encouraged states and territories to carefully consider the NHMRC's advice. However, decisions about the delivery of public healthcare services remain the responsibility of individual jurisdictions.
The Northern Territory has also maintained restrictions on the treatment, demonstrating that the issue extends beyond Queensland.
The NHMRC is expected to continue developing comprehensive national clinical guidelines for the care of transgender and gender-diverse people under 18. These guidelines are scheduled for release in 2028 and are intended to provide a more consistent framework for healthcare professionals across Australia.
For now, Queensland's existing policy remains in place, and no immediate change to public healthcare access has been announced.
The discussion is expected to continue as medical organisations, families, policymakers and advocacy groups examine the evidence and consider how healthcare decisions should be made in the future.
NSW patient survey findings highlight safety concerns in several major hospitals, as the state government commits additional security staff to emergency...
The ACT Government has released early designs for a major hospital expansion in Bruce, featuring new clinical facilities, additional beds, an emergency...
Q fever is a bacterial disease that can spread from infected animals, particularly cattle, sheep and goats, to humans. People can become infected by breathing in contaminated du...
A new $37 million cardiac hybrid theatre has officially opened at Rockhampton Hospital, bringing advanced heart treatment facilities to Central Queensla...
A proposed school sports field development at Canoe Point in Tannum Sands has been paused after environmental concerns were raised about clearing native...
A teenage boy was taken to Townsville University Hospital in serious condition after being rescued from the water at Crystal Creek in North Queensland.
Following violent attacks involving food delivery workers, the Transport Workers' Union is calling for stronger protections, improved safety measures an...
Victorian detectives have arrested a teenager following an investigation into alleged organised crime attacks targeting bars, clubs and restaurants acro...
South Australian police have arrested a man and a woman after allegedly discovering 910 alkaloid poppy plants growing at a residential property in Brahm...
A 15-year-old boy has been left in critical condition after being shot with an arrow in Kempsey, while police investigate reports involving people alleg...
Two teenage boys have suffered stab wounds during a violent confrontation at Castle Towers Shopping Centre in Sydney's north-west, prompting an emergenc...